Acute mood improvement after dextroamphetamine and methylphenidate in narcolepsy

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness.
• Stimulant medications are commonly prescribed to manage narcolepsy symptoms.
• The impact of these stimulants on mood and cognitive function in narcoleptic patients warrants further investigation.

Purpose of the Study:

• To investigate the mood changes induced by dextroamphetamine (D-AMP) and methylphenidate (MPH) in patients with narcolepsy.
• To compare the effects of D-AMP and MPH on various mood states.
• To explore the potential therapeutic benefits of these stimulants beyond excessive sleepiness.

Main Methods:

• A study involving 40 narcoleptic patients.
• Utilized the Profile of Mood Status (POMS) and eight additional adjectives to assess mood.
• Mood was measured before and 90 minutes after stimulant medication (D-AMP or MPH) ingestion.

Main Results:

• No significant differences were observed between the effects of D-AMP and MPH on mood.
• Combined data showed increased ratings for Vigour-Activity, confidence, talkativeness, and competitiveness.
• Significant reductions were noted in Fatigue-Inertia, Depression-Dejection, and Confusion-Bewilderment (P < 0.001).

Conclusions:

• Stimulant medications (D-AMP and MPH) positively impact mood in narcolepsy patients.
• These findings suggest a therapeutic role for stimulants in improving affect, vigour, and cognition, in addition to alleviating sleepiness.
• The observed mood effects are consistent with those seen in healthy subjects and other patient groups.